TPCN2 and neurodegenerative disease: Therefore, in consideration of the occurrence of dysfunctional autophagy in neurodegeneration, targeting the lysosomal TPC2 channel has been suggested as a therapeutic strategy for new drugs’ development in the treatment of neurodegenerative diseases (Fig. 2).